NFKB1 and cancer: Treatment with NF-κB inhibitor Bay11-7082 significantly decreased the inhibitory effect of Gyp-L on cancer cell growth (Figure 5B), as well as the percentage of SA-β-gal positive cell population (Figure 5D).